Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past?
Tuesday, May 12, 2020 - 12:31
in Biology & Nature
CanSino Biologics, Johnson & Johnson, and the University of Oxford are all using genetically engineered common cold viruses to make COVID-19 vaccines. The technology is more than 30 years in the making, but it's yet to yield an effective vaccine for humans